Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Divi's Laboratories Ltd

NSE: DIVISLAB · BSE: 532488 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹9,619.50
Market cap: ₹2,55,368 Cr
Revenue (annual): ₹10,560 Cr
Net profit (annual): ₹2,568 Cr
P/E (TTM): 87.3×Sector 50.4×
Promoter holding: 51.88%+0.00% QoQ
FII holding: 20.19%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Financial Results 2 Earnings Call 2 Promoter Selling 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

1 Aug 2026 11:34 IST NSE

Financial ResultsAlfa Alert

Divi's Laboratories Q1 FY27 Results: Net Profit ₹902 Cr, Up 65.5% YoY

Divi's Laboratories Ltd reported revenue from operations of ₹3,080 Cr (+27.8% YoY) and net profit of ₹902 Cr (+65.5% YoY) for Q1 FY27.

Key figure: Net profit ₹902 Cr · +65.5% YoY

Open full results → Read the filing ↗

23 May 2026 12:12 IST BSE

Financial Results

Divi's Laboratories Q4 FY26 Results: Net Profit ₹751 Cr, Up 13.4% YoY

Divi's Laboratories Ltd reported revenue from operations of ₹2,831 Cr (+9.5% YoY) and net profit of ₹751 Cr (+13.4% YoY) for Q4 FY26.

Key figure: Net profit ₹751 Cr · +13.4% YoY

Open full results → Read the filing ↗